Cash & equivalents increased 38.1%
Cash & equivalents changed +38.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +38.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +17.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +364.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +292.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +1546 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +16.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +43.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed +151 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed -1.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.